Advertisement

Letter to the editor regarding jewell letter to the editor regarding: Risk of breast implant associated anaplastic large cell lymphoma in a cohort of 3546 women prospectively followed long term after reconstruction with macro-textured breast implants

Published:November 26, 2020DOI:https://doi.org/10.1016/j.bjps.2020.11.006
      Upon reading Dr. Mark Jewell's letter regarding Dr. Peter Cordeiro's report of his personal series of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
      • Cordeiro P.G.
      • Ghione P.
      • Ni A.
      • et al.
      Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured implants.
      , I felt a response was indicated on several fronts.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cordeiro P.G.
        • Ghione P.
        • Ni A.
        • et al.
        Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured implants.
        J Plast Reconstr Aesthet Surg. 2020; 73: 841-846
        • Adams W.P.
        • Culbertson E.
        • Deva A.
        • Magnusson M.
        • Layt C.
        • Jewell M.
        • Mallucci P.
        • Heden P
        Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants.
        Plast Reconstr Surg. 2017; 140: 427-431
        • DeCoster R.C.
        • Lynch E.B.
        • Bonaroti A.R.
        • et al.
        Breast Implant-Associated Anaplastic Large Cell Lymphoma: defining Future Research Priorities.
        Clin Plast Surg. January 2021; (Accepted for publication)
        • McGuire P.
        • Reisman N.R.
        • Murphy D.K
        Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants.
        Plast Reconst Surg. 2017; 139: 1-9
        • Magnusson M.
        • Beath K.
        • Cooter R.
        • et al.
        The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants.
        Plast Reconstr Surg. 2019; 143: 1285-1292

      Linked Article